Vasculogenic mimicry (VM) describes the formation of pseudo blood vessels constructed of
tumor cells that have acquired endothelial-like properties. VM channels endow the tumor …

Vasculogenic mimicry (VM) describes a process by which cancer cells establish an
alternative perfusion pathway in an endothelial cell-free manner. Despite its strong …

Tumor cells transform into endothelial cells by epithelial-to-mesenchymal transition, which is
characterized by vasculogenic mimicry (VM). VM not only accelerates tumor progression but …

Vasculogenic mimicry (VM) is a nonangiogenesis-dependent pathway that promotes tumor
growth and disease progression. Nodal signaling has several vital roles in both embryo …

Enhanced neovasculogenesis, especially vasculogenic mimicry (VM), contributes to the
development of triple-negative breast cancer (TNBC). Breast tumor-initiating cells (BTICs) …

Antiangiogenesis therapy is one of the most promising approaches to cancer treatment. Its
clinical success has come out but still too limited. Vascularization of tumor is a complex and …

Vasculogenic mimicry (VM) is a blood supply modality that occurs independently of
endothelial cell angiogenesis. Hypoxia and the epithelial-mesenchymal transition (EMT) …

Purpose The occurrence of vasculogenic mimicry (VM) and EphA2-mediated tumour
progression are associated with poor prognosis in various solid tumours. Here, we aimed to …

Vasculogenic mimicry (VM) differs from the classical tumor angiogenesis model. VM does
not depend on endothelial cells; instead, highly aggressive tumor cells mimic endothelial …

Background Vasculogenic mimicry (VM) is a recently discovered angiogenetic process
found in many malignant tumors, and is different from the traditional angiogenetic process …